systemic-lupus-erythematosus

Documents about systemic-lupus-erythematosus

• Vitamin D Supplementation in Systemic Lupus Erythematosus#851335ClinicalTrials.gov
• The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus#864749ClinicalTrials.gov
• A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus#889856ClinicalTrials.gov
• Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus#967938ClinicalTrials.gov
• Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus#861924ClinicalTrials.gov
• EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study#839041ClinicalTrials.gov
• Engagement in CHildhood-Onset Systemic Lupus#835335ClinicalTrials.gov
• Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus Erythematosus#917570ClinicalTrials.gov
• An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus#906398ClinicalTrials.gov
• SII and SIRI as Prognostic Biomarkers in Lupus Nephritis#832661ClinicalTrials.gov
• The Effect of Listening to Qur'an Recital on Quality of Life in Systemic Lupus Erythematosus Patients#826327ClinicalTrials.gov
• The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)#839404ClinicalTrials.gov
• The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients#840964ClinicalTrials.gov
• A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)#842983ClinicalTrials.gov
• International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus#872326ClinicalTrials.gov
• Ultraviolet Light Therapy for Systemic Lupus Erythematosus#893839ClinicalTrials.gov
• Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus#1007193ClinicalTrials.gov
• Lupus and Observance#840341ClinicalTrials.gov
• A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus#876817ClinicalTrials.gov
• Lupus Intervention for Fatigue Trial#914789ClinicalTrials.gov
• Myocardial Inflammation in Systemic Lupus Erythematosus#846153ClinicalTrials.gov
• Anifrolumab Pregnancy Study#895974ClinicalTrials.gov
• Intervention to Improve Communication and Medication Adherence in Lupus#900692ClinicalTrials.gov
• An explainable machine learning model for predicting in-hospital infection in patients with systemic lupus erythematosus.#437399PubMed
• A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus#834732ClinicalTrials.gov
• CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus#862379ClinicalTrials.gov
• Study During Pregnancy of Expression of miRNAs in RA or SLE#915413ClinicalTrials.gov
• Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus#969669ClinicalTrials.gov
• Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study#853317ClinicalTrials.gov
• A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis#1008529ClinicalTrials.gov
• Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)#411303ClinicalTrials.gov
• Multi-cohort transcriptomic analysis with machine learning identifies interferon-related candidate genes in systemic lupus erythematosus.#276007PubMed
• Interrogating the role of type I interferon in the dysregulation of AhR activity in systemic lupus erythematosus#347570Harvard DASH
• Vagus Nerve Stimulation for Fatigue in Systemic Lupus#857886ClinicalTrials.gov
• Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)#830801ClinicalTrials.gov
• Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients#868624ClinicalTrials.gov
• Laser Puncture and Program of Lifestyle Modification in Lupus Females#916482ClinicalTrials.gov
• Lupus Walking Intervention to Address Fatigue/Quality of Life#982189ClinicalTrials.gov
• A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLE#277436Repositorio Universidad Peruana Cayetano Heredia
• Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus#885481ClinicalTrials.gov
• Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients#893704ClinicalTrials.gov
• Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus#899424ClinicalTrials.gov
• Early methylprednisolone pulses and prevention of long-term damage accrual in active systemic lupus erythematosus: a propensity score analysis of the Lupus–Cruces–Bordeaux cohort#145117HAL (France)
• A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)#801037ClinicalTrials.gov
• Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity#865107ClinicalTrials.gov
• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease#845891ClinicalTrials.gov
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)#847414ClinicalTrials.gov
• Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification#805684ClinicalTrials.gov
• Gene expression profiling of dendritic cell tolerance dysfunction in women with systemic lupus erythematosus#294621HAL (France)
• Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus#882604ClinicalTrials.gov